Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Variant Histology in Pediatric NLPBL: Adverse Biology Mitigated by R-CHOP, Including Feasible Early-Stage De-Escalation

HL - 247

Variant Histology in Pediatric NLPBL: Adverse Biology Mitigated by R-CHOP, Including Feasible Early-Stage De-Escalation

Nesreen Ali

Poster Presenter: Nesreen Ali

Thumbnail for MRD-Guided vs Fixed-Duration Targeted Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Progression-Free Survival and Depth of Response

CLL - 250

MRD-Guided vs Fixed-Duration Targeted Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Progression-Free Survival and Depth of Response

Sameer Bhimani

Poster Presenter: Sameer Bhimani

Previous 1...17 18 19 20 21 22 23...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Distinct Inpatient and Post-Discharge Risk States Defined by AKI and Acute Dialysis in Multiple Myeloma Hospitalizations

MM - 251

Distinct Inpatient and Post-Discharge Risk States Defined by AKI and Acute Dialysis in Multiple Myeloma Hospitalizations

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

AML - 252

Transfer-Pathway Vulnerability, Not Final Hospital Type, Defines Early Mortality Risk in Acute Promyelocytic Leukemia: National NIS/NRD Data, 2016-2022

Woo Joo Lee

Poster Presenter: Woo Joo Lee

Thumbnail for Outcomes of Children With Down Syndrome and B-Cell Acute Lymphoblastic Leukemia Treated With a Reduced-Methotrexate Strategy in JCCG ALL-B12

ALL - 253

Outcomes of Children With Down Syndrome and B-Cell Acute Lymphoblastic Leukemia Treated With a Reduced-Methotrexate Strategy in JCCG ALL-B12

Shunsuke Yamamoto

Poster Presenter: Shunsuke Yamamoto

Thumbnail for Characteristics of Mycosis Fungoides: A Cohort Analysis From a Real-World Single Oncology Center

TCL - 255

Characteristics of Mycosis Fungoides: A Cohort Analysis From a Real-World Single Oncology Center

Ahmed Ibrahim

Poster Presenter: Ahmed Ibrahim

Thumbnail for “EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study”

AML - 256

“EASIX Score Predicts Severe Acute GVHD and Mortality After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Study”

Juliana Faleschini

Poster Presenter: Juliana Faleschini

Thumbnail for Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated with Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study

ABCL - 257

Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated with Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study

Juliana Faleschini

Poster Presenter: Juliana Faleschini

Thumbnail for Impact of Clonal Hematopoiesis on Outcomes After Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Autologous and Allogeneic Transplantation

CT - 259

Impact of Clonal Hematopoiesis on Outcomes After Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Autologous and Allogeneic Transplantation

Nain Tara

Poster Presenter: Nain Tara

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors